Concepedia

Michael A. Collier

MA

Statistics

Publications

27

Citations

997

H-Index

21

Active since

1983

Affiliations

University of North Carolina at Chapel Hill(Current)

The Ohio State University

Oklahoma State University

Michigan State University

University of Oklahoma Health Sciences Center

Michael A. Collier is an author at University of North Carolina at Chapel Hill specializing in drug delivery, pharmacy, and medicine.

Publications per year

1983–2018

27

Publications

27

A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination

Robert D. Junkins, Matthew D. Gallovic, Brandon M. Johnson et al. · Journal of Controlled Release · 2017 · 151 citations

, , +16

Tunable degradation of acetalated dextran microparticles enables controlled vaccine adjuvant and antigen delivery to modulate adaptive immune responses

Naihan Chen, Monica M. Johnson, Michael A. Collier et al. · Journal of Controlled Release · 2018 · 90 citations · Full text

, , +17

Acetalated Dextran Microparticles for Codelivery of STING and TLR7/8 Agonists

Michael A. Collier, Robert D. Junkins, Matthew D. Gallovic et al. · Molecular Pharmaceutics · 2018 · 81 citations

, , +17

Progesterone and calcitriol attenuate inflammatory cytokines CXCL1 and CXCL2 in ovarian and endometrial cancer cells

Leyla Kavandi, Michael A. Collier, Viqar Syed · Journal of Cellular Biochemistry · 2012 · 56 citations

, , +17

Balancing the normal foot: hoof preparation, shoe fit and shoe modification in the performance horse

Olin K. Balch, D. Butler, Michael A. Collier · Equine Veterinary Education · 1997 · 49 citations

, , +16

1–5 of 27